Nuclide Therapeutics raised £5 million seed investment round w/ Marathon Beteiligungs AG.

Biotech Health services Pharma

United Kingdom

Germany

Investments

12 September 2025

Share:

Nuclide Therapeutics (company)

United Kingdom

Biotech Health services Pharma

Total investments received (USD): 6.72m

Round value (USD): 6.72m

Round investors: Marathon Beteiligungs AG

Company: Nuclide Therapeutics

Industry: Biotech Health services Pharma

Related deals

Entourage AI in a £3.8M pre-seed raise led by Provision, joined by GU Holdings and angel investors.

AI (big data) Biotech Health services Software Services

United Kingdom

Investments 01 March 2026

Brainomix in a £4.8 million Series C extension co-led by Parkwalk and Hostplus, joined by Modi Ventures.

AI (big data) Biotech Health services Software Services

United Kingdom

Australia

United States

Investments 13 February 2026

Centauri Therapeutics secured a £6 million series A extension investment from the AMR Action Fund,

Biotech Health services

United Kingdom

United States

Investments 08 February 2026

Tozaro in a £6M financing round with equity contributed by Mercia Ventures and Midlands Engine Investment Fund in the UK

Biotech Health services Manufacturing Pharma Software Services

United Kingdom

Investments 06 February 2026

NuVision raises £4.8M in an equity round led by Mercia Ventures, University of Nottingham and Pioneer in the UK

Biotech Health services Manufacturing

United Kingdom

Investments 06 January 2026